Home -> Law Blog Directory -> Personal Injury Law Blogs -> A Georgia Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: A Georgia LawyerFDA Warns Drug Makers On Misleading Promotional Efforts
The letters were sent in recent weeks to several companies and posted on the FDA's website this week.
The FDA said a 60-second television advertisement for Sepracor's Lunesta sleep aid makes "unsubstantiated superiority claims" in violation of federal law. A voice-over in the ad says viewers who have trouble sleeping even after taking a sleep aid should ask their doctors about switching to Lunesta because Lunesta is "different." The ad says Lunesta "keys into receptors that support sleep."
The FDA said this language misleadingly implies that Lunesta is clinically superior to other insomnia medications, and that Lunesta might work where others fail. The agency says it isn't aware of any evidence to support these claims. Also, the agency said the claim about how Lunesta works is misleading because there's still some uncertainty about the drug's mechanism of action.
Full post as published by A Georgia Lawyer on June 22, 2010 (boomark / email).
Mitchell Report Summary
Report on Steroid Drug Use in Major League Baseball by Senator George Mitchell
Drug Manufacturer Rebates
Caremark Corp. agrees to pay $38.5 million settlement after convincing doctors to switch drug brands.
AARP Insurance
alleging misleading medical insurance policies.
Sunscreen Manufacturers Face Class Actions over Misleading Advertising
Banana Boat, Coppertone Face Class Action in Canada
FDA Warns of Potentially Fatal Errors with GDH-PQQ Glucose Monitoring Technology
Glucose Monitoring Technology FDA Warns of Potentially Fatal Errors
FDA
Warns of Extortion Scam by FDA Impersonators
FDA Issues Warning Regarding Topical Ibuprofen Drug Products
Topical Ibuprofen Drug Products FDA Issues Warning Letters

FDA Warns 14 Drugmakers Over Misleading Ads
Drug makers take Vytorin ads off the air
Ethics Rules May be Tightened for Drug and Medical Device Makers
Mukasey Warns of Drug Case Releases









